Loading But Tiba says it needs access to an mRNA manufacturing facility in Australia to make the vaccines at a commercial scale on our shores. The Moderna rejection has forced the company and the ...

US pharmaceutical and biotechnology company Moderna has opened a new vaccine manufacturing facility in the Australian state of Victoria. Located at Monash University’s Clayton campus in ...

In absolute dollar amount, the Cambridge drugmaker had the biggest drop in market cap among any public Massachusetts company ...

Morgan Stanley slashed its price target on Moderna Inc (BMV:MRNA) (NASDAQ:MRNA) to $38 from $70 given the lowered revenue ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

In the mRNA vaccine maker’s 2024 Shareholder Letter, CEO Stéphane Bancel reflected upon the company’s second year ...